Spironolactone is a mineralocorticoid receptor antagonist used as a potassium-sparing diuretic to treat hypokalemia, hyperaldosteronism, and dermatologic conditions associated with androgens [68]. This evidence concerns the gene NR3C2 and hyperaldosteronism.